Research Publications

Back

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer


Bowtell, DD; Bohm, S; Ahmed, AA; Aspuria, PJ; Bast, RC, Jr; Beral, V; Berek, JS; Birrer, MJ; Blagden, S; Bookman, MA; Brenton, JD; Chiappinelli, KB; Martins, FC; Coukos, G; Drapkin, R; Edmondson, R; Fotopoulou, C; Gabra, H; Galon, J; Gourley, C; Heong, V; Huntsman, DG; Iwanicki, M; Karlan, BY; Kaye, A; Lengyel, E; Levine, DA; Lu, KH; McNeish, IA; Menon, U; Narod, SA; Nelson, BH; Nephew, KP; Pharoah, P; Powell, DJ, Jr; Ramos, P; Romero, IL; Scott, CL; Sood, AK; Stronach, EA; Balkwill, FR
2015-10-23
Nat Rev Cancer
Journal Article
15
11
668-79
High-grade serous ovarian cancer (HGSOC) accounts for 70-80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.
NPG
Stem Cells and Cancer
10.1038/nrc4019
26493647
Refer to copyright notice on published article.

Back
Creation Date 2015-10-28 01:52:44 Last Modified 2015-10-28 01:56:41